Page last updated: 2024-10-22

4-(acetylamino)benzeneacetic acid and Rheumatoid Arthritis

4-(acetylamino)benzeneacetic acid has been researched along with Rheumatoid Arthritis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Ghislat, G1
Rahman, T1
Ballester, PJ1
Tanaka, H1
Abe, T1
Nishimura, S1
Sakai, H1
Kimura, H1
Oki, M1
Nojima, M1
Taga, M1
Matsumoto, S1
Takahashi, H1
Imai, K1
Kawasaki, Y1
Moriyama, M1
Shibata, K1
Gomita, Y1
Kusabe, T1
Waguri-Nagaya, Y1
Tanikawa, T1
Aoyama, M1
Fukuoka, M1
Kobayashi, M1
Otsuka, T1
Asai, K1
Takeba, Y1
Suzuki, N1
Wakisaka, S1
Nagafuchi, H1
Mihara, S1
Kaneko, A1
Asai, T1
Sakane, T1
Sakurai, T1
Iso, T1
Inoue, H1
Sano, K1
Takeuchi, K1
Takagishi, K1

Reviews

1 review available for 4-(acetylamino)benzeneacetic acid and Rheumatoid Arthritis

ArticleYear
[A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2004, Volume: 27, Issue:3

    Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Therapy, C

2004

Trials

1 trial available for 4-(acetylamino)benzeneacetic acid and Rheumatoid Arthritis

ArticleYear
[Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents].
    Ryumachi. [Rheumatism], 2001, Volume: 41, Issue:3

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Drug Resistance; Drug Therapy, Combina

2001

Other Studies

4 other studies available for 4-(acetylamino)benzeneacetic acid and Rheumatoid Arthritis

ArticleYear
Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.
    Biomolecules, 2020, 11-19, Volume: 10, Issue:11

    Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Carbonic Anhydrase II; Dose-R

2020
[Examination of the escape phenomenon in disease modifying antirheumatic drugs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:3

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cysteine

2005
The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.
    Rheumatology international, 2005, Volume: 25, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cells; Cells, Cul

2005
Effects of actarit on synovial cell functions in patients with rheumatoid arthritis.
    The Journal of rheumatology, 1999, Volume: 26, Issue:1

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cell Adhesion; Cell Adhesion Molecules; Collagenases; C

1999